Cytovance Biologics announces Plasmid DNA Manufacturing: An Optimized Platform Process Webinar
June 14, 2021 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, June 14, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene therapy...
Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing
March 08, 2021 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Cytovance Biologics announces Regulatory Strategies for Gene Therapy Product Development webinar
February 08, 2021 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, Okla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene...